glp 1 dementia study The EVOKE trials found that semaglutide, the GLP-1 drug behind several popular diabetes and weight loss medications, did not meaningfully slow cognitive decline in people with Alzheimer's disease. Despite these findings, scientists Can popular diabetes and weight-loss

Maile LA, Badley-Clarke J, Clemmons DR

We conducted X-ray diffraction experiments and MD simulations for structural elucidation of the different TRaQ-G adducts to gain mechanistic insight into the varying GSH sensitivities of the molecules

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes TrialLipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

This results in more profound and sustained appetite reduction, leading to greater caloric deficit and weight loss

PMID 28340347